APR 12, 2019 8:15 AM PDT

Pulmonary Hypertension in Sarcoidosis

WRITTEN BY: Dena Aruta

Sarcoidosis is an inflammatory disease that involves the formation of non-caseating granulomas, a cluster of macrophages, in response to a foreign substance or antigen in the body, They can be found in any organ system, but 90% of people diagnosed have it in their lungs. The granulomas (also called nodules) can be found in the interstitial tissues (around the air sacs), thoracic lymph nodes, and the vascular system of the lungs.

Pulmonary arterial hypertension (PAH) is increased pulmonary arterial pressure that is characterized by increased pulmonary vascular resistance that can lead to failure of the right ventricle of the heart. It can be life-threatening if not treated. PAH is seen as a complication in sarcoidosis from 5-28% of patients and at rates as high as 74% of those with advanced disease. Sarcoidosis-associated PAH has been shown to worsen its prognosis and may increase the risk of death 7-fold. 

Management of PAH in sarcoidosis is not well understood, and there are currently no specific treatments approved. Kishan Parikh and colleagues published the results of their study on patient characteristics, clinical outcomes, treatment, and management strategies of sarcoidosis-associated PAH  in the journal, Scientific Reports. They followed a large cohort of biopsy-proven sarcoidosis patients with PAH from Duke University for 11 years. "Our primary outcomes of interest were change in 6-minute walk distance (6MWD) and change in N-terminal pro-brain natriuretic peptide (NT-proBNP) by after therapy," states Dr. Parikh. 

Out of the 95 participants who met the criteria for the study, 70% had stage IV pulmonary sarcoidosis, and 77% had functional class III/IV symptoms (marked or severe activity limitations and comfortable only at rest). The median NT-proBNP value was elevated (910 pg/mL), and right ventricular dysfunction was moderate/severe in 55% of patients. The mortality rate over an average of three years was 32% with a mean time to hospitalization or death at six months. 

The authors report three major findings: (1) high morbidity that reflects the disease burden with both pulmonary hypertension and stage IV pulmonary sarcoidosis, (2) no change in the six-minute walk test with PAH-specific treatment, and (3) 37 patients receiving PAH-specific therapy had a 51% improvement in their NT-proBNP. 

In this lecture by Dr. Maddipati from the Division of Pulmonary and Critical Care Medicine at East Carolina University, he gives an overview of sarcoidosis-associated PAH and current treatment strategies. Ultimately, patients who are diagnosed with sarcoidosis-associated PAH should be evaluated for possible lung transplantation. 

About the Author
  • After earning my Bachelor of Science degree in biology/chemistry from Virginia Polytechnic Institute and State University (aka Va. Tech), I went on to complete clinical rotations in laboratory medicine at Roanoke Memorial Hospital. I spent the next 21 years working in healthcare as a clinical microbiologist. In 2015, I combined my fascination with medicine and passion for writing into a freelance career, and I haven't looked back. Even though my expertise is in microbiology and infectious diseases, I'm adept at writing about any medical topic. Being a freelance writer allows me to pursue a career where I can work at home with my two feline assistants, Luke and Grace. I'm a firm supporter of animal rights and volunteer for a local rescue during my free time. 
You May Also Like
MAR 18, 2021
Immunology
"Brainwashed" Immune Cells Help Breast Tumors Thrive
MAR 18, 2021
"Brainwashed" Immune Cells Help Breast Tumors Thrive
Immunologists have discovered a mechanism through which immune cells get recruited into breast cancer tumors, and instea ...
MAR 17, 2021
Health & Medicine
CBD Inhibits Brain Changes that Initiate  Alzheimer's: Animal Study
MAR 17, 2021
CBD Inhibits Brain Changes that Initiate Alzheimer's: Animal Study
Cannabidiol, or CBD — the main non-psychoactive ingredient in cannabis — may inhibit some triggers for Alzhe ...
MAR 30, 2021
Cardiology
Looking at a Fertility Drug's Cardiac Safety
MAR 30, 2021
Looking at a Fertility Drug's Cardiac Safety
New drugs go through a long and arduous process before they can grace a doctor’s office. One of the last steps is ...
APR 13, 2021
Cardiology
Can a Ketosis Metabolite Act as a Biomarker for Cardiovascular Diseases?
APR 13, 2021
Can a Ketosis Metabolite Act as a Biomarker for Cardiovascular Diseases?
Quick and reliable diagnostics are the key to controlling many diseases, including cardiovascular disease. Biomarkers ar ...
APR 15, 2021
Immunology
COVID Vaccines Protect Breastfeeding Babies Too
APR 15, 2021
COVID Vaccines Protect Breastfeeding Babies Too
Good news for families of newborns: A new study shows that breastfeeding mothers who receive a COVID vaccine share prote ...
APR 12, 2021
Health & Medicine
Chronic Pain Patients Can Find Long-Term Success Using Cannabis
APR 12, 2021
Chronic Pain Patients Can Find Long-Term Success Using Cannabis
Many users report immediate pain relief from using medical cannabis, but now a recently published study suggests chronic ...
Loading Comments...